[go: up one dir, main page]

ATE251624T1 - Granulatimide-derivate zur behandlung von krebs - Google Patents

Granulatimide-derivate zur behandlung von krebs

Info

Publication number
ATE251624T1
ATE251624T1 AT99908706T AT99908706T ATE251624T1 AT E251624 T1 ATE251624 T1 AT E251624T1 AT 99908706 T AT99908706 T AT 99908706T AT 99908706 T AT99908706 T AT 99908706T AT E251624 T1 ATE251624 T1 AT E251624T1
Authority
AT
Austria
Prior art keywords
granulatimide
cancer
derivatives
treatment
iii
Prior art date
Application number
AT99908706T
Other languages
English (en)
Inventor
Raymond J Andersen
Michel Roberge
Jasbinder Sanghera
Danny Leung
Roberto G S Berlinck
Sao Paulo De
Edward Piers
Robert Britton
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27170646&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE251624(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CA 2232074 external-priority patent/CA2232074A1/en
Priority claimed from CA002245029A external-priority patent/CA2245029A1/en
Application filed by Univ British Columbia filed Critical Univ British Columbia
Application granted granted Critical
Publication of ATE251624T1 publication Critical patent/ATE251624T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044Pyrrole radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/06Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT99908706T 1998-03-13 1999-03-11 Granulatimide-derivate zur behandlung von krebs ATE251624T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CA 2232074 CA2232074A1 (en) 1998-03-13 1998-03-13 Granulatimide compounds as g2 checkpoint inhibitors
CA002245029A CA2245029A1 (en) 1998-03-13 1998-08-14 Granulatimide compounds as g2 checkpoint inhibitors
US09/258,991 US6291447B1 (en) 1998-03-13 1999-02-26 Granulatimide compounds and uses thereof
PCT/CA1999/000224 WO1999047522A1 (en) 1998-03-13 1999-03-11 Granulatimide derivatives for use in cancer treatment

Publications (1)

Publication Number Publication Date
ATE251624T1 true ATE251624T1 (de) 2003-10-15

Family

ID=27170646

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99908706T ATE251624T1 (de) 1998-03-13 1999-03-11 Granulatimide-derivate zur behandlung von krebs

Country Status (6)

Country Link
EP (1) EP1070068B2 (de)
JP (1) JP2002506868A (de)
AT (1) ATE251624T1 (de)
AU (1) AU758241B2 (de)
DE (1) DE69911935T3 (de)
WO (1) WO1999047522A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE361752T1 (de) 1998-09-25 2007-06-15 Cephalon Inc Methoden zur prophylaxe und behandlung von schäden der wahrnehmungshärchenzellen und der cochlearen neuronen
US6841567B1 (en) 1999-02-12 2005-01-11 Cephalon, Inc. Cyclic substituted fused pyrrolocarbazoles and isoindolones
CA2395284A1 (en) * 1999-12-23 2001-07-05 The Ontario Cancer Institute Inhibition of gsk-3.beta.
GB0008264D0 (en) * 2000-04-04 2000-05-24 Smithkline Beecham Plc Novel method and compounds
US7122679B2 (en) 2000-05-09 2006-10-17 Cephalon, Inc. Multicyclic compounds and the use thereof
US7129250B2 (en) 2000-05-19 2006-10-31 Aegera Therapeutics Inc. Neuroprotective and anti-proliferative compounds
CA2308994A1 (en) * 2000-05-19 2001-11-19 Aegera Therapeutics Inc. Neuroprotective compounds
AUPR500201A0 (en) 2001-05-14 2001-06-07 Commonwealth Scientific And Industrial Research Organisation Recovery of minerals by flotation
ES2369534T3 (es) 2002-06-06 2011-12-01 Canbas Co. Ltd. Compuestos que anulan el punto de control g2 del ciclo celular inducido por daños en el adn y/o que incrementan la actividad anticancerosa de los tratamientos que dañan el adn.
FR2845995A1 (fr) * 2002-10-16 2004-04-23 Servier Lab Nouveaux derives de pyrrolo[3,4-c]carbazole et de pyrido[2,3-b]pyrrolo[3,4-e]indole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP2258357A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP1942879A1 (de) 2005-10-31 2008-07-16 Braincells, Inc. Gaba-rezeptor-vermittelte modulation von neurogenese
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス,インコーポレイティド アンジオテンシン調節による神経新生
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2009127059A1 (en) * 2008-04-15 2009-10-22 Alethia Biotherapeutics Inc. Complexes of isogranulatimide and granulatimide with a cyclodextrm, formulations and their use for the treatment of cancer
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
CN103864890B (zh) * 2012-12-12 2016-09-14 浙江医药股份有限公司新昌制药厂 咪唑异丙乙酰茶氨酸苄酯并吡啶并吲哚、其制备、纳米结构及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3835842A1 (de) * 1988-10-21 1990-04-26 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE3803620A1 (de) * 1988-02-06 1989-08-17 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
WO1991009034A1 (en) * 1989-12-14 1991-06-27 Schering Corporation Indolocarbazoles from saccharothrix aerocolonigenes subsp. copiosa subsp. nov. scc 1951 atcc 53856
DE3942296A1 (de) * 1989-12-21 1991-06-27 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung
WO1994004541A2 (en) * 1992-08-12 1994-03-03 The Upjohn Company Protein kinase inhibitors and related compounds combined with taxol
WO1994007895A1 (en) * 1992-09-25 1994-04-14 Schering Corporation Diindolo compounds and pharmaceutical compositions containing them
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
SG63570A1 (en) * 1993-12-07 1999-03-30 Lilly Co Eli Protein kinase c inhibitors
US5604219A (en) * 1994-03-18 1997-02-18 Kyowa Hakko Kogyo Co., Ltd. Indolocarbazole derivatives that stimulate platelet production
WO1995032976A1 (en) * 1994-06-01 1995-12-07 Ciba-Geigy Ag Polycyclic lactam derivatives for sensitizing multidrug-resistant cells to antitumour agents
EP0763041A1 (de) * 1994-06-01 1997-03-19 Novartis AG Indolocarbazol-derivate zur sensibilisierung resistenter zellen gegen antitumormittel
US5827846A (en) * 1994-06-01 1998-10-27 Novartis Corp. Carbazole derivatives as agents against multi-drug resistance
US5705511A (en) * 1994-10-14 1998-01-06 Cephalon, Inc. Fused pyrrolocarbazoles
EA000967B1 (ru) * 1995-11-20 2000-08-28 Эли Лилли Энд Компани Ингибитор протеинкиназы c
NZ323282A (en) * 1995-11-20 1999-01-28 Lilly Co Eli N,n'-bridged bisindolylmaleimides and their use to prepare n,n'-bridged bisindolylmaleimides
FR2755691B1 (fr) * 1996-11-08 1998-12-04 Adir Nouveaux derives 7,12-dioxa-benzo[a]anthraceniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
JP2002506868A (ja) 2002-03-05
AU2821999A (en) 1999-10-11
DE69911935T3 (de) 2008-02-07
DE69911935D1 (de) 2003-11-13
WO1999047522A1 (en) 1999-09-23
AU758241B2 (en) 2003-03-20
EP1070068B2 (de) 2007-01-17
EP1070068A1 (de) 2001-01-24
DE69911935T2 (de) 2004-09-09
EP1070068B1 (de) 2003-10-08

Similar Documents

Publication Publication Date Title
ATE251624T1 (de) Granulatimide-derivate zur behandlung von krebs
ATE264846T1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
ATE383339T1 (de) Amin-derivate zur behandlung von apoptosis
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
BR9908332A (pt) Derivados de n-[carbonil(anel di ou triaza diinsaturado de cinco membros substituìdo)] derivados de guanidina para tratamento de esquemia
BR0007589A (pt) Inibidores da proliferação de células
DE69732120D1 (de) Trizyklische inhibitoren der farnesyl protein transferase
TR199800924T2 (xx) Quinoline t�revleri.
ES2191208T3 (es) Oxiimino-pregnano-carbolactonas.
ATE227293T1 (de) 2,3-disubstituierte-(5,6)-heteroarylkondensiert - pyrimidin-4-one
ES2243579T3 (es) Derivados de pirazolopirideno.
DE69330282D1 (de) Chinolon und acridinon derivate zur behandlung der harninkontinenz
EE04777B1 (et) Kasvajavastased ühendid, neid sisaldavad farmatseutilised kompositsioonid ning nende kasutamine
EA200000431A3 (ru) Новые замещенные димерные соединения, способ их получения и фармацевтические композиции, содержащие их
EE03771B1 (et) Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
ATE170852T1 (de) Benzolsulfonamid-derivate zur behandlung der blaseninstabilität
EA200000996A1 (ru) Конденсированные с арилом азаполициклические соединения
ATE237585T1 (de) Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung
DE69127976D1 (de) Tropolonderivate und pharmazeutische zubereitungen davon zur vorbeugung und behandlung von ischämischen krankheiten
TR199802044T2 (xx) Yeni karbon asidi t�revleri, �retilmeleri ve kullan�mlar�.
ES2019840A6 (es) Procedimiento para preparar nuevos derivados de tieno-triazolo-diazepina.
EA199900534A1 (ru) Имидазопиридазины
DE69330601D1 (de) Serotoninergische ergolin derivate
ATE148109T1 (de) Hiv-proteaseinhibitoren und ihre verwendung zur behandlung von aids
SE9604582D0 (sv) Novel compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties